Myositis-specific and myositis-associated antibodies in overlap myositis in comparison to primary dermatopolymyositis: Relevance for clinical classification: Retrospective study of 169 patients

Joint Bone Spine

Volumn 77, Issue 2, 2010, Pages 125-130

  Váncsa, Andrea ^a   Gergely, Lajos ^a   Ponyi, Andrea ^b   Lakos, Gabriella ^a   Németh, Júlia ^c   Szodoray, Péter ^a   Dankó, Katalin ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Idiopathic inflammatory myopathy (IIM); Immunosuppressive therapy; Myositis associated antibodies (MAA); Myositis specific antibodies (MSA); Overlap syndrome

Indexed keywords

ANTINUCLEAR ANTIBODY; AZATHIOPRINE; CENTROMERE ANTIBODY; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IMMUNOGLOBULIN; JO 1 ANTIBODY; LA ANTIBODY; METHOTREXATE; METHYLPREDNISOLONE; RIBONUCLEOPROTEIN ANTIBODY; RO ANTIBODY;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DERMATOMYOSITIS; DISEASE CLASSIFICATION; DRUG DOSE REDUCTION; FEMALE; HUMAN; HUNGARY; MAJOR CLINICAL STUDY; MALE; MYOSITIS; POLYMYOSITIS; PREVALENCE; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; CROSS-SECTIONAL STUDIES; DERMATOMYOSITIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; POLYMYOSITIS; RETROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77949772754     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2009.08.008     Document Type: Article

References (25)

1. Bohan A., and Peter J.B. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292 (1975) 403-407
2. Bohan A., and Peter J.B. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292 (1975) 344-347
3. Mastaglia F.L., Garlepp M.J., Phillips B.A., et al. Inflammatory myopathies: clinical, diagnostic and therapeutic aspects. Muscle Nerve 27 (2003) 407-425
4. Hirakata M., Suwa A., Takada T., et al. Clinical and immunogenetic features of patients with autoantibodies to asparaginyl-transfer RNA synthetase. Arthritis Rheum 56 (2007) 1295-1303
5. Troyanov Y., Targoff I.N., Tremblay J.L., et al. Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients. Medicine (Baltimore) 84 (2005) 231-249
6. Koenig M., Fritzler M.J., Targoff I.N.Y., et al. Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes. Arthritis Res Ther 9 (2007) R78
7. Ponyi A., Borgulya G., Constantin T., et al. Functional outcome and quality of life in adult patients with idiopathic inflammatory myositis. Rheumatology (Oxford) 44 (2005) 83-88
8. Arnett F.C., Edworthy S.M., Bloch D.A., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31 (1988) 315-324
9. Tojo T., and Honma M. Preliminary criteria in SLE classification--result of adaptation on ARA preliminary criteria. Ryumachi 13 (1973) 228-233
10. Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
11. Marie I., Hachulla E., Hatron P.Y., et al. Polymyositis and dermatomyositis: short-term and long-term outcome, and predictive factors of prognosis. J Rheumatol 28 (2001) 2230-2237
12. Love L.A., Leff R.L., Fraser D.D., et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 70 (1991) 360-374
13. Brouwer R., Hengstman G.J., Vree E.W., et al. Autoantibody profiles in the sera of European patients with myositis. Ann Rheum Dis 60 (2001) 116-123
14. Hengstman G.J., Brouwer R., Egberts W.T., et al. Clinical and serological characteristics of 125 Dutch myositis patients. Myositis-specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies. J Neurol 249 (2002) 69-75
15. Hausmanowa-Petrusewicz I., Kowalska-Oledzka E., Miller F.W., et al. Clinical, serologic, and immunogenetic features in Polish patients with idiopathic inflammatory myopathies. Arthritis Rheum 40 (1997) 1257-1266
16. Venables P.J. Polymyositis-associated overlap syndromes. Br J Rheumatol 35 (1996) 305-306
17. Toll A., Monfort J., Benito P., et al. Sclerodermatomyositis associated with severe arthritis. Dermatol Online J 10 (2004) 18
18. Jury E.C., D'Cruz D., and Morrow W.J. Autoantibodies and overlap syndromes in autoimmune rheumatic disease. J Clin Pathol 54 (2001) 340-347
19. Alderuccio F., Chan E.K., and Tan E.M. Molecular characterization of an autoantigen of PM-Scl in the polymyositis/scleroderma overlap syndrome: a unique and complete human cDNA encoding an apparent 75-kD acidic protein of the nucleolar complex. J Exp Med 173 (1991) 941-952
20. Brouwer R., Vree Egberts W.T., Hengstman G.J., et al. Autoantibodies directed to novel components of the PM/Scl complex, the human exosome. Arthritis Res 4 (2002) 134-138
21. Hietarinta M., Meyer O., Haim T., et al. Antinuclear and antinucleolar antibodies in patients with scleroderma-polymyositis overlap syndrome. Br J Rheumatol 35 (1996) 1326-1327
22. Bluthner M., and Bautz F.A. Cloning and characterization of the cDNA coding for a polymyositis-scleroderma overlap syndrome-related nucleolar 100-kD protein. J Exp Med 176 (1992) 973-980
23. Ranque B., Authier F.J., Berezne A., et al. Systemic sclerosis-associated myopathy. Ann NY Acad Sci 1108 (2007) 268-282
24. Gaudin C., Fortenfant F., Adoue D., et al. Anti PM-Scl antibodies. Study of prevalence and of meaning. Rev Med Interne 27 (2006) 665-670
25. Garton M.J., and Isenberg D.A. Clinical features of lupus myositis versus idiopathic myositis: a review of 30 cases. Br J Rheumatol 36 (1997) 1067-1074